The rising prevalence in GLP-1 agonists for diabetes has generated a question about delivery routes : skin-applied devices versus pills . Usually , GLP-1 therapies were only available in tablet form, but https://aishaeflb883677.weblogco.com/41255175/glp-1-transdermal-delivery-systems-vs-oral-medications-what-suitable-for-the-patient